Q4 2025 · 13F-HR
North Peak Capital Management, LLCholdings as filed
Filed 2026-02-13 · accession 0001213900-26-015983
$1.18B
Reported value
10
Positions
2025-12-31
Period end
The Brief · North Peak Capital Management, LLC · Q4 2025
AI · grounded in 13F
North Peak Capital Management, LLC established a new position in SE valued at $28.27M. The fund also increased its holdings in HAE by 204.39% and DRVN by 37.29%. Conversely, the manager trimmed its stake in ELV by 45.02% and reduced SCHW by 22.57%.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 46137V357 | RSP | INVESCO EXCHANGE TRADED FD T | $263.2M | 22.4% | 1,374,131 | PUT | SOLE |
| 43283X105 | HGV | HILTON GRAND VACATIONS INC | $231.4M | 19.7% | 5,171,995 | Common | SOLE |
| 146869102 | CVNA | CARVANA CO | $164.6M | 14.0% | 390,023 | Common | SOLE |
| 705573103 | PEGA | PEGASYSTEMS INC | $143.3M | 12.2% | 2,400,065 | Common | SOLE |
| 808513105 | SCHW | SCHWAB CHARLES CORP | $123.4M | 10.5% | 1,234,682 | Common | SOLE |
| 405024100 | HAE | HAEMONETICS CORP MASS | $88.4M | 7.51% | 1,102,992 | Common | SOLE |
| 26210V102 | DRVN | DRIVEN BRANDS HLDGS INC | $59.1M | 5.03% | 3,990,850 | Common | SOLE |
| 036752103 | ELV | ELEVANCE HEALTH INC FORMERLY | $48.7M | 4.14% | 138,991 | Common | SOLE |
| 81141R100 | SE | SEA LTD | $28.3M | 2.40% | 221,599 | Common | SOLE |
| 00857U107 | AGL | AGILON HEALTH INC | $26.3M | 2.23% | 38,139,937 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.